tiprankstipranks
B.R.A.I.N. Biotechnology Research and Information Network AG (DE:BNN)
XETRA:BNN
Germany Market

B.R.A.I.N. Biotechnology Research and Information Network (BNN) Financial Statements

Compare
9 Followers

B.R.A.I.N. Biotechnology Research and Information Network Financial Overview

B.R.A.I.N. Biotechnology Research and Information Network's market cap is currently €71.22M. The company's EPS TTM is €-0.509; its P/E ratio is ―; B.R.A.I.N. Biotechnology Research and Information Network is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22Sep 21Sep 20
Income Statement
Total Revenue€ 54.63M€ 55.34M€ 49.51M€ 38.39M€ 38.23M
Gross Profit€ 30.33M€ 3.47M€ 27.45M€ 21.57M€ 21.20M
Operating Income€ -8.85M€ -6.71M€ -6.89M€ -7.83M€ -7.99M
EBITDA€ -4.23M€ -1.98M€ -1.30M€ 2.01M€ -4.92M
Net Income€ -11.13M€ -8.28M€ -6.34M€ -4.68M€ -9.02M
Balance Sheet
Cash & Short-Term Investments€ 27.41M€ 5.41M€ 8.80M€ 24.65M€ 19.05M
Total Assets€ 88.74M€ 70.94M€ 77.99M€ 77.74M€ 72.15M
Total Debt€ 4.15M€ 4.66M€ 3.04M€ 2.64M€ 30.60M
Net Debt€ -23.02M€ -693.00K€ -5.41M€ -21.90M€ 11.65M
Total Liabilities€ 74.85M€ 47.92M€ 43.74M€ 35.91M€ 46.01M
Stockholders' Equity€ 12.62M€ 21.77M€ 29.64M€ 38.78M€ 20.79M
Cash Flow
Free Cash Flow€ -5.31M€ -6.86M€ -7.57M€ -5.17M€ -7.63M
Operating Cash Flow€ -3.58M€ -4.22M€ -1.49M€ -3.91M€ -4.77M
Investing Cash Flow€ -1.69M€ 562.00K€ -12.69M€ -2.18M€ -4.47M
Financing Cash Flow€ 26.99M€ 459.00K€ -1.97M€ 11.57M€ 13.09M
Currency in EUR

B.R.A.I.N. Biotechnology Research and Information Network Earnings and Revenue History

B.R.A.I.N. Biotechnology Research and Information Network Debt to Assets

B.R.A.I.N. Biotechnology Research and Information Network Cash Flow

B.R.A.I.N. Biotechnology Research and Information Network Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis